Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:2567
SEHK:2567Software

Qiniu (SEHK:2567) Loss Narrows To C¥33.4m Challenging Persistent Bearish Narratives

Qiniu (SEHK:2567) has opened FY 2025 with first half revenue of C¥829.4 million and a basic EPS loss of C¥0.02 per share, alongside a net income loss of C¥33.4 million. This sets a cautious tone for investors watching the company’s path toward profitability. The company has seen first half revenue move from C¥710.4 million in FY 2024 to C¥829.4 million in FY 2025, while basic EPS shifted from a loss of C¥0.41 to a smaller loss of C¥0.02. This frames a set of results where revenue scale and...
NYSE:WY
NYSE:WYSpecialized REITs

Weyerhaeuser (WY) Valuation Check After Recent Share Price Weakness And CCS Growth Prospects

Weyerhaeuser (WY) is back on investors’ radar after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months and year. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Weyerhaeuser. The recent 14.47% 1 month share price decline, alongside a 20.31% 1 year total shareholder return decline, suggests momentum has been fading as investors reassess Weyerhaeuser’s risk and earnings profile around the current...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Valuation Check After Norton Revamp AI Reputation Tool Launch

Norton parent Gen Digital (GEN) is in focus after Norton Revamp, an AI-powered online presence builder, joined its cyber safety portfolio. This development is raising fresh questions about how new AI tools might shape the stock’s appeal. See our latest analysis for Gen Digital. At a share price of US$20.97, Gen Digital has seen a 1-day share price return of 1.99% and a 7-day share price return of 1.40%, set against a 30-day share price return of 9.22% and a year-to-date share price return of...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS) Swings to Profitability and Guides Higher Revenue – Is This Inflection Durable?

In March 2026, One Stop Systems, Inc. reported full-year 2025 results showing sales of US$30.5 million and revenue of US$32.22 million, with net income of US$5.09 million versus a net loss a year earlier and earnings per share turning positive. The company also issued full-year 2026 guidance calling for revenue growth of 20% to 25%, signaling management’s confidence after moving from losses to profitability. Now we’ll examine how the swing to profitability and management’s 2026 revenue...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Is Alliant Energy (LNT) Fairly Priced After Recent Share Price Pullback?

Wondering if Alliant Energy’s current share price reflects its real worth, or if you might be paying too much for a regulated utility stock right now? The stock last closed at US$68.71, with a 7 day return of a 5.6% decline, a 30 day return of a 1.2% decline, a 1 year return of 12.5%, a 3 year return of 46.9%, and a 5 year return of 49.7%. These moves have come as investors continue to reassess regulated utilities as an income and stability option. Alliant Energy has attracted attention as...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

A Look At Expand Energy (EXE) Valuation After Recent Share Price Momentum

Without a fresh headline to react to, many investors are looking at how Expand Energy (EXE) fits into the current natural gas sector, focusing on its recent share performance and underlying earnings profile. See our latest analysis for Expand Energy. At a share price of $107.32, Expand Energy has seen a 7.84% one-month share price return, while its one-year total shareholder return of 3.08% and five-year total shareholder return of 213.15% indicate momentum that has built over the longer...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music And Netflix Deal Puts Undervalued Shares In Focus

Warner Music Group (NasdaqGS:WMG) has entered into a multiyear creative partnership with Netflix for exclusive first look documentaries and films. The deal focuses on projects built around Warner Music artists and songwriters, covering both archival stories and new original concepts. The agreement grants Netflix priority access to Warner Music developed filmed content ideas before they are pitched elsewhere. For you as an investor, this move sits at the intersection of music, video...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Is CrowdStrike (CRWD) Turning FedRAMP High AI Security Wins Into Durable Platform Advantage?

In March 2026, CrowdStrike and several partners announced a wave of AI-driven security launches and FedRAMP High-authorized capabilities for the Falcon platform, extending protection across U.S. federal XIoT, GovCloud, and emerging AI workloads. By embedding Falcon into federal clouds, enterprise AI factories, Nebius AI Cloud, and tools like Perplexity’s Comet Enterprise, CrowdStrike is pushing its platform deeper into the core infrastructure where AI and critical operations now run. We’ll...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

Assessing ABIVAX (ENXTPA:ABVX) After Its Huge Biotech Rally And Pipeline Headlines

If you are wondering whether ABIVAX Société Anonyme is priced attractively after its huge run, or if the current share price already reflects the story, this article breaks down what the numbers say about value. The stock last closed at €109.40, with a 7 day return of 8.1%, a 30 day return showing a 0.9% decline, a year to date return showing a 4.9% decline, and a 1 year gain that is very large compared to where it started. Recent news coverage has focused on ABIVAX Société Anonyme as a high...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

Is Snap (SNAP) Now A Potential Opportunity After Its Sharp Share Price Slide

Wondering if Snap at around US$4.48 is a bargain or a value trap? This article will help you frame that question using several different valuation angles. The share price has faced heavy pressure, with a 44.9% decline year to date and a 52.0% decline over the last 12 months. Changes like this can influence how the market views both its growth potential and risk profile. Recent coverage has focused on Snap's position as a social media and messaging platform, its user engagement, and how it is...
ASX:WGX
ASX:WGXMetals and Mining

Why Westgold Resources (ASX:WGX) Is Down 14.8% After Securing A$600m In New Revolving Facilities

Westgold Resources Limited has recently executed syndicated loan documentation for A$600,000,000 of unsecured revolving financing facilities with five Tier 1 lenders, alongside Board approval to expand the Higginsville Processing Hub from 1.6Mtpa to 2.6Mtpa following a positive Definitive Feasibility Study. Together, the new long-term, undrawn funding capacity and the Higginsville expansion decision point to a materially higher level of balance sheet flexibility and processing capability for...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

A Look At SolarEdge Technologies (SEDG) Valuation After Analyst Upgrades And Demand Rebound Hopes

SolarEdge Technologies (SEDG) grabbed attention after a 12.7% jump, as Jefferies and Bank of America upgraded the stock, citing a potential demand rebound, regained top U.S. inverter share and a stronger earnings outlook. See our latest analysis for SolarEdge Technologies. The sharp 13.29% 1 day share price return to US$51.73 sits on top of a 47.97% 30 day and 78.01% 90 day share price return. The 1 year total shareholder return of about 3x contrasts with a 5 year total shareholder return...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

A Look At Nasdaq (NDAQ) Valuation As SEC Backs Tokenized Securities Trading

SEC approval puts Nasdaq’s tokenization plans in focus The SEC’s decision to let certain securities listed on Nasdaq (NDAQ) trade and settle in tokenized form on blockchain, combined with its Payward partnership, is drawing fresh attention to the stock’s role in digital assets. See our latest analysis for Nasdaq. Nasdaq’s recent tokenization announcements sit against a mixed share price backdrop, with a 6.06% 1 month share price return but a 10.68% decline year to date. At the same time, a 1...
TASE:MTAV
TASE:MTAVCapital Markets

A Look At Meitav Investment House (TASE:MTAV) Valuation After Record 2025 Earnings And Global Equity Raise

Why Meitav Investment House Stock Is Back in Focus After Record 2025 Results Meitav Investment House (TASE:MTAV) is drawing fresh attention after reporting full year 2025 results that set records for revenue, profitability, and assets under management, along with a global equity raise backed by international institutions. The company reported 2025 revenue of ₪2,010 million versus ₪1,619 million a year earlier, with net income of ₪843 million compared with ₪256 million. Basic earnings per...
NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Skyworks Qorvo Merger Reshapes RF Scale And Diversification Story

Skyworks Solutions (NasdaqGS:SWKS) and Qorvo have agreed to merge, bringing together two long time rivals in radio frequency chip manufacturing. The companies plan to combine their product portfolios for mobile devices and connectivity solutions, subject to regulatory and shareholder approvals. The announcement reflects a move toward greater scale and broader customer coverage in key wireless and connectivity markets. For you as an investor, this merger brings two established radio...
NYSE:STZ
NYSE:STZBeverage

A Look At Constellation Brands (STZ) Valuation After Mixed Recent Share Price Performance

What recent returns say about Constellation Brands today Constellation Brands (STZ) has seen a 1.5% decline over the past day and a small loss over the past week, while the share price shows a larger decline over the past year. At a recent close of US$149.62, the stock is down about 4% over the past month but up roughly 11% in the past 3 months. This gives investors mixed short-term and more recent longer-period performance signals. See our latest analysis for Constellation Brands. The recent...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk’s GLP-1 Leadership Tested By FDA Warnings And Rising Rivals

Novo Nordisk (NYSE:NVO) has received two recent FDA warnings related to its GLP-1 franchise. The company is experiencing rising GLP-1 competition from Eli Lilly and newer entrants such as Pfizer. These developments are emerging as revenue growth slows and margins come under pressure. Novo Nordisk, best known for its diabetes and obesity treatments, now finds its GLP-1 leadership under closer regulatory and competitive scrutiny. While recent attention has focused on valuation and telehealth...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

EU Complaint Over VMware Licensing Puts Broadcom’s Software Strategy Under Scrutiny

European cloud infrastructure providers have filed a competition complaint with the EU against Broadcom (NasdaqGS:AVGO) over recent VMware licensing changes. The complaint, brought by industry group CISPE, alleges abuse of market position through the termination of prior VMware partner programs and tougher new license terms. Complainants are asking the European Commission to impose interim measures to halt the alleged practices and restore access to earlier partner arrangements. For...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Assessing Viatris (VTRS) Valuation As Investor Event Outlines Long Term Plans Through 2030

Viatris (VTRS) has drawn fresh attention after announcing an Investor Event where leaders plan to lay out the company’s vision through 2030, including growth drivers, pipeline plans, portfolio choices, and capital return priorities. See our latest analysis for Viatris. Viatris shares currently trade at US$13.20, with a 30-day share price return of 17.76% decline, a 90-day share price return of 10.65%, and a 1-year total shareholder return of 50.99%. If the Investor Event has you thinking...
NYSE:TPC
NYSE:TPCConstruction

A Look At Tutor Perini (TPC) Valuation After Recent Share Price Pullback And Record Backlog Growth

Tutor Perini (TPC) has drawn investor attention after recent share price swings, including a 4.1% decline over the past day and a 14.5% drop over the past month, despite solid reported profitability and revenue. See our latest analysis for Tutor Perini. The recent 1 day share price return of 4.1% decline and 30 day share price return of 14.5% decline sit in sharp contrast to a very large 1 year total shareholder return. This suggests momentum has cooled after a strong run as investors...
TSX:CCL.B
TSX:CCL.BPackaging

A Look At CCL Industries (TSX:CCL.B) Valuation After Recent Share Price Softness

Why CCL Industries is on investors’ radar today CCL Industries (TSX:CCL.B) is back in focus after recent share price softness, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for CCL Industries. At around CA$83.60, the recent 3.2% 7 day and 4% month share price declines contrast with a 19% 1 year total shareholder return. This suggests some momentum has cooled after a solid longer term run. If...
TSX:HPS.A
TSX:HPS.AElectrical

Hammond Power Solutions (TSX:HPS.A) Margin Compression Challenges Bullish Expansion Narrative

Hammond Power Solutions (TSX:HPS.A) just wrapped up FY 2025 with fourth quarter revenue of $254.1 million and basic EPS of $1.28, alongside trailing twelve month EPS of $6.07 on revenue of $898.3 million. Over recent periods, revenue has moved from $208.5 million in Q4 2024 to $254.1 million in Q4 2025, while quarterly EPS has shifted from $1.99 to $1.28. This sets up a picture where top line scale and reported profit growth sit next to a net margin line that investors will be watching...
SEHK:6136
SEHK:6136Water Utilities

Kangda International Environmental (SEHK:6136) Margin Improvement Challenges Long‑Term Bearish Narratives

Kangda International Environmental (SEHK:6136) has just posted its FY 2025 first half results, with revenue of C¥1.2b and basic EPS of C¥0.05, against a backdrop of 41.2% year over year earnings growth on a trailing twelve month basis. Over recent periods the company has seen revenue move from C¥1.1b in 1H 2024 to C¥1.2b in 2H 2024 and C¥1.2b in 1H 2025. Basic EPS has ranged between C¥0.03 and C¥0.05 across those halves as trailing EPS reached C¥0.11. With trailing net margins at 9.8%...
NYSE:DGX
NYSE:DGXHealthcare

How Investors May Respond To Quest Diagnostics (DGX) Expanding Blood-Based Cancer Screening And Boardroom Expertise

In recent weeks, Guardant Health and Helio Genomics each announced agreements with Quest Diagnostics to distribute their blood-based colorectal and liver cancer screening tests through Quest’s nationwide network, while the Quest board also appointed experienced healthcare executive Timothy Wentworth as a new director. Together, these moves deepen Quest’s role as an access point for innovative cancer detection while adding boardroom expertise in scaling complex healthcare platforms and...